Aspen Aerogels, Inc. (NYSE:ASPN) Given Consensus Recommendation of “Hold” by Analysts

Shares of Aspen Aerogels, Inc. (NYSE:ASPN) have been assigned a consensus rating of “Hold” from the ten analysts that are currently covering the firm, Marketbeat.com reports. Three equities research analysts have rated the stock with a sell recommendation, two have assigned a hold recommendation, four have given a buy recommendation and one has given a strong buy recommendation to the company. The average 1 year price target among analysts that have issued a report on the stock in the last year is $12.6667.

Several equities analysts recently issued reports on the company. Zacks Research cut Aspen Aerogels from a “hold” rating to a “strong sell” rating in a research note on Monday, November 10th. Barclays dropped their price objective on shares of Aspen Aerogels from $6.00 to $4.00 and set an “underweight” rating on the stock in a research note on Friday, November 7th. Weiss Ratings restated a “sell (d-)” rating on shares of Aspen Aerogels in a research note on Monday. Finally, Canaccord Genuity Group dropped their price target on Aspen Aerogels from $10.00 to $5.00 and set a “buy” rating on the stock in a research report on Friday, November 7th.

Insider Transactions at Aspen Aerogels

In other news, CEO Donald R. Young sold 56,845 shares of the business’s stock in a transaction on Thursday, November 13th. The shares were sold at an average price of $3.23, for a total transaction of $183,609.35. Following the completion of the transaction, the chief executive officer owned 494,011 shares of the company’s stock, valued at approximately $1,595,655.53. The trade was a 10.32% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Insiders own 4.30% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the company. Nisa Investment Advisors LLC raised its holdings in shares of Aspen Aerogels by 1,094.8% during the second quarter. Nisa Investment Advisors LLC now owns 4,791 shares of the construction company’s stock valued at $28,000 after buying an additional 4,390 shares during the last quarter. SBI Securities Co. Ltd. raised its stake in Aspen Aerogels by 67.3% during the 2nd quarter. SBI Securities Co. Ltd. now owns 6,343 shares of the construction company’s stock valued at $38,000 after acquiring an additional 2,551 shares in the last quarter. Tower Research Capital LLC TRC raised its stake in Aspen Aerogels by 184.6% during the 2nd quarter. Tower Research Capital LLC TRC now owns 7,235 shares of the construction company’s stock valued at $43,000 after acquiring an additional 4,693 shares in the last quarter. Acadian Asset Management LLC acquired a new position in Aspen Aerogels during the 1st quarter worth $43,000. Finally, Probity Advisors Inc. bought a new position in shares of Aspen Aerogels in the second quarter worth $63,000. Institutional investors own 97.64% of the company’s stock.

Aspen Aerogels Price Performance

ASPN opened at $3.32 on Thursday. The company has a market capitalization of $273.98 million, a P/E ratio of -0.89 and a beta of 2.95. The company has a 50-day moving average of $5.67 and a 200-day moving average of $6.39. The company has a debt-to-equity ratio of 0.28, a quick ratio of 3.33 and a current ratio of 3.94. Aspen Aerogels has a 1-year low of $2.92 and a 1-year high of $14.30.

Aspen Aerogels (NYSE:ASPN) last posted its quarterly earnings results on Thursday, November 6th. The construction company reported ($0.06) EPS for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.05). Aspen Aerogels had a negative return on equity of 0.20% and a negative net margin of 86.52%.The firm had revenue of $73.02 million during the quarter, compared to analyst estimates of $73.42 million. During the same quarter last year, the business posted ($0.17) earnings per share. The firm’s revenue for the quarter was down 37.8% on a year-over-year basis. Aspen Aerogels has set its FY 2025 guidance at -4.150–4.050 EPS. Equities analysts expect that Aspen Aerogels will post 0.17 EPS for the current fiscal year.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.